DHT Holdings Inc. vs ImmunityBio Inc. Common Stock — how do they compare? DHT Holdings Inc. trades at $24.98 (market cap $3.82B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.7× DHT Holdings Inc.'s market cap, and DHT Holdings Inc. pays a 20.58% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold DHT Holdings Inc. for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| DHT | IBRX | |
|---|---|---|
Market Cap | $3.82B | $10.33B |
Volume | 3,845,643 | 11,745,198 |
Sector | Industrials | Health |
52-Week High | $24.93 | $11.55 |
52-Week Low | $11.20 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.10B | $10.79B |
Dividend Yield | 20.58% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
DHT Holdings operates a fleet of crude oil tankers that trade on international routes. Its fleet consists of very large crude carriers, or VLCCs.
Read more on DHT →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →